FXR Deficiency Causes Reduced Atherosclerosis inLdlr−/−Mice
- 1 October 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (10) , 2316-2321
- https://doi.org/10.1161/01.atv.0000235697.35431.05
Abstract
Objective— Based on the observation that Fxr−/− mice exhibit a proatherogenic lipoprotein profile, we investigated the role of FXR in the development of atherosclerosis. Methods and Results— Administration of a western diet to Fxr−/− mice or wild-type mice does not result in the development of significant atherosclerotic lesions. Consequently we generated Fxr−/−Ldlr−/− (DKO) mice and compared lesion development with Ldlr−/− mice. After 16 weeks on a Western diet, en face analysis of the aorta indicated that the male DKO mice had reduced atherosclerotic lesions as compared with Ldlr−/− mice. Plasma low-density lipoprotein cholesterol and high-density lipoprotein cholesterol levels were reduced by 40% to 50%, whereas triglyceride levels increased 4-fold in the male DKO mice. Finally, peritoneal macrophages freshly isolated from male DKO mice had reduced expression of CD36 mRNA and decreased neutral lipid accumulation, as compared with Ldlr−/− mice. Conclusions— FXR deficiency in male, but not female, Ldlr−/− mice results in a reduction in the size of atherosclerotic lesions in the aorta. The reduction in atherosclerosis may result from a decrease in plasma low-density lipoprotein cholesterol, coupled with reduced expression of CD36 in macrophages of DKO mice. Based on the observation that Fxr−/− mice exhibit a proatherogenic lipoprotein profile, we investigated the role of FXR in the development of atherosclerosis. FXR deficiency in male, but not female, Ldlr−/− mice results in a reduction in the size of atherosclerotic lesions in the aorta. The reduction in atherosclerosis may result from a decrease in plasma low-density lipoprotein cholesterol, coupled with reduced expression of CD36 in macrophages of DKO mice.Keywords
This publication has 30 references indexed in Scilit:
- Farnesoid X receptor is essential for normal glucose homeostasisJournal of Clinical Investigation, 2006
- Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient miceJournal of Lipid Research, 2005
- Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic miceJournal of Clinical Investigation, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Hyplip2 , a New Gene for Combined Hyperlipidemia and Increased AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional ActivationJournal of Biological Chemistry, 2003
- AtherosclerosisCell, 2001
- A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and AtherogenesisMolecular Cell, 2001
- Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in miceJournal of Clinical Investigation, 2000
- Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cellsSeminars in Cell & Developmental Biology, 1999